6 Steps for Optimizing Recombinant Antibody Expression
White Paper Feb 26, 2020
Monoclonal antibodies (mAbs) have pioneered discovery and development in biological science and medicine, playing an increasingly important role in research and drug discovery.
To meet this rising demand, researchers have developed alternative methods to accelerate antibody production – the generation of recombinant antibodies (rAbs), often in mammalian cell lines.
Since antibodies can possess a wide range of different characteristics, it is crucial that expression conditions are optimized for each individual rAb.
In this white paper, discover the steps to optimizing rAb expression, including how to:
- Choose an expression host
- Design an expression vector
- Choose a purification method
Related White Papers
It is paramount within the pharmaceutical industry that scientists can manage large amounts of data efficiently and safely. The Cubis® II balance series was designed for customizable modularity, meeting the needs of the industry whilst maintaining full compliance.
READ MORESingle-cell sequencing is quickly becoming a standard tool in biological research due to the scale and depth of insight it provides across diverse cell populations. The pharmaceutical industry is exploiting single-cell approaches to identify novel therapeutic targets and accelerate promising assets through development.
READ MOREAccess this whitepaper to discover a system that performs virtual screening at ultra-high-throughput scale, requires minimal costs and can be run with cloud computing or HPC resources.
READ MORELike what you just read? You can find similar content on the communities below.
Applied Sciences Cancer Research Drug Discovery Immunology & MicrobiologyTo personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free
LOGIN SUBSCRIBE FOR FREE
